[ASA-intolerance syndrome and persistent rhinosinusitis : Differential diagnosis and treatment]
- PMID: 25929893
- DOI: 10.1007/s00106-015-0008-7
[ASA-intolerance syndrome and persistent rhinosinusitis : Differential diagnosis and treatment]
Abstract
Background: A differential diagnosis of persistent chronic rhinosinusitis is ASA-intolerance syndrome (AIS), also known as Aspirin®‑exacerbated respiratory disease (AERD), Samter-Trias (Samter's disease, Morbus Widal). Particularly in cases of frequent recurrency of nasal polyps in combination with bronchial asthma and hypersensitivity reactions to acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAR) can often be referred to an underlying AIS. The pathogenesis of this syndrome is attributed to a misallocation of the arachidonic acid metabolism, resulting in an increased leukotriene production.
Methods: The diagnosis may be difficult in the early stages of the disease with incomplete triad of symptoms.
Results: Therapy may consist of paranasal sinuses surgery, drug therapy and adaptive deactivation as the only causal treatment option for patients with AIS.
Conclusion: For adaptive desactivation, positive effects were actually shown even in patients with long-term recurrent or persistent complaints of chronic rhinosinusitis.
Similar articles
-
Aspirin-exacerbated respiratory disease: characteristics and management strategies.Expert Rev Clin Immunol. 2015;11(7):805-17. doi: 10.1586/1744666X.2015.1039940. Epub 2015 May 2. Expert Rev Clin Immunol. 2015. PMID: 25936612 Review.
-
The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.J Allergy Clin Immunol. 2021 Mar;147(3):827-844. doi: 10.1016/j.jaci.2020.10.043. Epub 2020 Dec 9. J Allergy Clin Immunol. 2021. PMID: 33307116 Free PMC article. Review.
-
Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.Am J Rhinol Allergy. 2018 Jul;32(4):280-286. doi: 10.1177/1945892418770260. Epub 2018 Apr 23. Am J Rhinol Allergy. 2018. PMID: 29682983
-
Upper airways in aspirin-exacerbated respiratory disease.Curr Opin Allergy Clin Immunol. 2015 Feb;15(1):21-6. doi: 10.1097/ACI.0000000000000122. Curr Opin Allergy Clin Immunol. 2015. PMID: 25546326 Review.
-
Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.Otolaryngol Clin North Am. 2023 Feb;56(1):107-124. doi: 10.1016/j.otc.2022.09.008. Epub 2022 Oct 22. Otolaryngol Clin North Am. 2023. PMID: 36283868 Review.
Cited by
-
[Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].HNO. 2018 Jan;66(1):38-74. doi: 10.1007/s00106-017-0401-5. HNO. 2018. PMID: 28861645 German. No abstract available.
-
[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps].HNO. 2021 Nov;69(11):868-877. doi: 10.1007/s00106-021-01018-z. Epub 2021 Mar 18. HNO. 2021. PMID: 33738558 Free PMC article. Review. German.
-
Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.Allergo J Int. 2018;27(2):56-65. doi: 10.1007/s40629-017-0048-5. Epub 2018 Jan 22. Allergo J Int. 2018. PMID: 29564208 Free PMC article. Review.
-
[Adaptive desensitization for acetylsalicylic acid hypersensitivity: A success story?].HNO. 2015 Oct;63(10):707-14. doi: 10.1007/s00106-015-0065-y. HNO. 2015. PMID: 26395185 Clinical Trial. German.
-
Level of sex hormones and their association with acetylsalicylic acid intolerance and nasal polyposis.PLoS One. 2020 Dec 17;15(12):e0243732. doi: 10.1371/journal.pone.0243732. eCollection 2020. PLoS One. 2020. PMID: 33332460 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical